Stroke registry: hemorrhagic vs ischemic strokes

Shiber, Joseph; Fontane, Emily; Adewale, Ademola

doi:10.1016/j.ajem.2008.10.026

Cited by 79 publications

(54 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In Portugal stroke is one of the leading causes of death, being mortality from stroke higher than ischemic heart disease mortality, unlike the european trend. Prevalence of ischemic stroke range from about 60% [2] to 85% among different populations, being ischemic stroke up to 10-times more frequent than hemorrhagic stroke in Western countries. [3] Thrombolysis has shown to be an effective treatment for acute ischemic stroke within 4.5 hours of onset of ischemic stroke, improving clinical outcome [4,5], not only reducing death but also dependency in activities of daily living [6].…”

Section: Introductionmentioning

confidence: 99%

Awareness Of Stroke Risk Factors And Warning Signs And Attitude To Acute Stroke

Duque

Fernandes²,

Correia

et al. 2015

Int Arch Med

View full text Add to dashboard Cite

Background: Stroke is a leading cause of death and disability worldwide. Knowledge of stroke risk factors and warning signs might improve its prevention and ensure prompt activation of emergency medical services and access to thrombolysis. Educational campaigns have been held in Portugal though its impact on knowledge of medical patients has not been assessed. Methods:A cross-sectional observational study was performed to medical outpatients, through an interview. Main objectives were to assess the extent of knowledge on risk factors and warning signs and the attitude to stroke and to identify predictive factors of strokerelated knowledge. Two sub-groups were studied: hypertensive and elderly.

show abstract

Section: Introductionmentioning

confidence: 99%

Awareness Of Stroke Risk Factors And Warning Signs And Attitude To Acute Stroke

Duque

Fernandes²,

Correia

et al. 2015

Int Arch Med

View full text Add to dashboard Cite

show abstract

“…Globally, it is responsible for nearly 5.5 million deaths every year, with 44 million disability-adjusted life-years lost which will increase up to 61 million in 2020 [2,4]. Of this, ischemic stroke accounts for approximately 73 to 86 %, whereas hemorrhagic stroke is responsible for 8 to 18 % of the cases [5].…”

Section: Introductionmentioning

confidence: 99%

The interplay of microRNAs and post-ischemic glutamate excitotoxicity: an emergent research field in stroke medicine

et al. 2016

View full text Add to dashboard Cite

Stroke is the second leading cause of death and the most common cause of adult disabilities among elderlies. It involves a complex series of mechanisms among which, excitotoxicity is of great importance. Also, miRNAs appear to play role in post-stroke excitotoxicity, and changes in their transcriptome occur right after cerebral ischemia. Recent data indicate that specific miRNAs such as miRNA-223, miRNA-181, miRNA-125a, miRNA-125b, miRNA-1000, miRNA-132 and miRNA-124a regulate glutamate neurotransmission and excitotoxicity during stroke. However, limitations such as poor in vivo stability, side effects and inappropriate biodistribution in miRNA-based therapies still exist and should be overcome before clinical application. Thence, investigation of the effect of application of these miRNAs after the onset of ischemia is a pivotal step for manipulating these miRNAs in clinical use. Given this, present review concentrates on miRNAs roles in post-ischemic stroke excitotoxicity.

show abstract

“…The prevalence of ischemic stroke is greater than hemorrhagic stroke. A research on 757 stroke patients conducted by Shiber, et al (2010) showed the incidence of ischemic stroke is 58.1% [4]. Another research revealed a higher percentage.…”

Section: Introductionmentioning

confidence: 99%

“…Another research revealed a higher percentage. According to research by Spurthi, et al, the incidence of ischemic stroke is 96% compared to hemorrhagic stroke (4%) [5].…”

Section: Introductionmentioning

confidence: 99%

Is There Any Benefit of Citicoline for Acute Ischemic Stroke ? Systematic Review of Current Evidences

Pinzon

Sanyasi²

2018

JCR

View full text Add to dashboard Cite

Two main strategies have been suggested for the treatment of ischemic stroke including reperfusion and neuroprotection. Citicoline is one of neuroprotector agent that commonly used in ischemic stroke. A systematic review of citicoline focusing only on ischemic stroke has not yet performed. This systematic review aimed to identify the effectiveness of citicoline in patients with ischemic stroke history. A systematic research was performed using PubMed and Cochrane Library as the database. Keywords were: "citicoline and stroke", "citicoline and ischemic stroke", and "randomized controlled trial citicoline". The inclusion criteria were: (i) the trials conducted between 2007 to 2017, (ii) written in English, (iii) the studies performed in human, (iv) patients had ischemic stroke history, (v) citicoline was the main drug assessed in the study. The exclusion criteria i.e.: (i) the study was not a randomized controlled trial (RCT) and (ii) the full text was not available. The quality of RCT was determined by using Jadad score. A literature search revealed 541 journals from PubMed and Cochrane Library. After screening the title and abstract, adjusting for inclusion and exclusion criteria, adjusting for the irrelevant topic, and duplication the final result was 4 RCT studies. All studies had a good quality, indicated by Jadad score of 3 or more. Three studies conclude that no statistically significant difference in treatment outcome between citicoline and other groups. The last study revealed citicoline is effective in preventing post-stroke cognitive impairment.

show abstract

Stroke registry: hemorrhagic vs ischemic strokes

Cited by 79 publications

References 8 publications

Awareness Of Stroke Risk Factors And Warning Signs And Attitude To Acute Stroke

Awareness Of Stroke Risk Factors And Warning Signs And Attitude To Acute Stroke

The interplay of microRNAs and post-ischemic glutamate excitotoxicity: an emergent research field in stroke medicine

Is There Any Benefit of Citicoline for Acute Ischemic Stroke ? Systematic Review of Current Evidences

Contact Info

Product

Resources

About